The latest closing stock price for Larimar Therapeutics as of June 25, 2025 is 3.25.
An investor who bought $1,000 worth of Larimar Therapeutics stock at the IPO in 2014 would have $-986 today, roughly -1 times their original investment - a -32.29% compound annual growth rate over 11 years.
The all-time high Larimar Therapeutics stock closing price was 616.08 on March 19, 2015.
The Larimar Therapeutics 52-week high stock price is 11.20, which is 244.6% above the current share price.
The Larimar Therapeutics 52-week low stock price is 1.61, which is 50.5% below the current share price.
The average Larimar Therapeutics stock price for the last 52 weeks is 5.11.
An investor who bought $1,000 worth of Larimar Therapeutics stock at the IPO in 2014 would have $-986 today, roughly -1 times their original investment - a -32.29% compound annual growth rate over 11 years.
The all-time high Larimar Therapeutics stock closing price was 616.08 on March 19, 2015.
The Larimar Therapeutics 52-week high stock price is 11.20, which is 244.6% above the current share price.
The Larimar Therapeutics 52-week low stock price is 1.61, which is 50.5% below the current share price.
The average Larimar Therapeutics stock price for the last 52 weeks is 5.11.